Amalgamated Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6M | Sell |
18,682
-55
| -0.3% | -$37.4K | 0.08% | 200 |
|
|
2026
Q1 | $14.5M | Sell |
18,737
-523
| -3% | -$400K | 0.11% | 149 |
|
|
2025
Q4 | $14.9M | Sell |
19,260
-180
| -0.9% | -$122K | 0.11% | 138 |
|
|
2025
Q3 | $10.9M | Sell |
19,440
-623
| -3% | -$352K | 0.08% | 190 |
|
|
2025
Q2 | $10.5M | Sell |
20,063
-557
| -3% | -$311K | 0.08% | 186 |
|
|
2025
Q1 | $13.1M | Buy |
20,620
+247
| +1% | +$170K | 0.11% | 148 |
|
|
2024
Q4 | $14.5M | Sell |
20,373
-2,447
| -11% | -$2.05M | 0.12% | 134 |
|
|
2024
Q3 | $24M | Buy |
22,820
+1,382
| +6% | +$1.54M | 0.2% | 79 |
|
|
2024
Q2 | $22.5M | Sell |
21,438
-296
| -1% | -$287K | 0.19% | 84 |
|
|
2024
Q1 | $20.9M | Sell |
21,734
-4,122
| -16% | -$3.92M | 0.18% | 95 |
|
|
2023
Q4 | $22.7M | Sell |
25,856
-1,191
| -4% | -$981K | 0.18% | 101 |
|
|
2023
Q3 | $22.3M | Sell |
27,047
-639
| -2% | -$502K | 0.19% | 90 |
|
|
2023
Q2 | $19.9M | Sell |
27,686
-3,012
| -10% | -$2.32M | 0.16% | 105 |
|
|
2023
Q1 | $25.2M | Buy |
30,698
+2,867
| +10% | +$2.16M | 0.22% | 88 |
|
|
2022
Q4 | $20.1M | Sell |
27,831
-1,962
| -7% | -$1.45M | 0.18% | 102 |
|
|
2022
Q3 | $20.5M | Buy |
29,793
+1,604
| +6% | +$1.01M | 0.2% | 84 |
|
|
2022
Q2 | $16.7M | Buy |
28,189
+354
| +1% | +$230K | 0.16% | 111 |
|
|
2022
Q1 | $19.4M | Sell |
27,835
-1,360
| -5% | -$860K | 0.15% | 105 |
|
|
2021
Q4 | $18.4M | Buy |
29,195
+1,753
| +6% | +$1.08M | 0.14% | 120 |
|
|
2021
Q3 | $16.6M | Sell |
27,442
-1,019
| -4% | -$633K | 0.14% | 118 |
|
|
2021
Q2 | $15.9M | Buy |
28,461
+22,413
| +371% | +$11.4M | 0.13% | 128 |
|
|
2021
Q1 | $2.86M | Sell |
6,048
-284
| -4% | -$138K | 0.11% | 148 |
|
|
2020
Q4 | $3.06M | Sell |
6,332
-24
| -0.4% | -$13K | 0.12% | 141 |
|
|
2020
Q3 | $3.56M | Sell |
6,356
-151
| -2% | -$91.6K | 0.15% | 107 |
|
|
2020
Q2 | $4.06M | Sell |
6,507
-5,723
| -47% | -$3.25M | 0.19% | 87 |
|
|
2020
Q1 | $5.97M | Sell |
12,230
-454
| -4% | -$187K | 0.15% | 134 |
|
|
2019
Q4 | $4.76M | Buy |
12,684
+683
| +6% | +$230K | 0.09% | 199 |
|
|
2019
Q3 | $3.33M | Buy |
12,001
+491
| +4% | +$145K | 0.07% | 250 |
|
|
2019
Q2 | $3.6M | Sell |
11,510
-614
| -5% | -$204K | 0.08% | 215 |
|
|
2019
Q1 | $4.98M | Buy |
12,124
+435
| +4% | +$179K | 0.12% | 160 |
|
|
2018
Q4 | $4.37M | Sell |
11,689
-327
| -3% | -$120K | 0.12% | 152 |
|
|
2018
Q3 | $4.86M | Sell |
12,016
-366
| -3% | -$139K | 0.12% | 163 |
|
|
2018
Q2 | $4.27M | Buy |
12,382
+813
| +7% | +$254K | 0.1% | 182 |
|
|
2018
Q1 | $3.98M | Buy |
11,569
+1,138
| +11% | +$396K | 0.11% | 188 |
|
|
2017
Q4 | $3.92M | Buy |
10,431
+1,008
| +11% | +$408K | 0.11% | 184 |
|
|
2017
Q3 | $4.21M | Buy |
9,423
+249
| +3% | +$118K | 0.13% | 147 |
|
|
2017
Q2 | $4.51M | Buy |
9,174
+3,327
| +57% | +$1.46M | 0.15% | 130 |
|
|
2017
Q1 | $2.27M | Sell |
5,847
-2,527
| -30% | -$937K | 0.11% | 159 |
|
|
2016
Q4 | $3.07M | Buy |
8,374
+1,468
| +21% | +$558K | 0.14% | 138 |
|
|
2016
Q3 | $2.78M | Sell |
6,906
-33
| -0.5% | -$13.2K | 0.16% | 107 |
|
|
2016
Q2 | $2.92M | Buy |
6,939
+3,824
| +123% | +$1.47M | 0.17% | 100 |
|
|
2016
Q1 | $1.12M | Buy |
3,115
+747
| +32% | +$308K | 0.11% | 173 |
|
|
2015
Q4 | $1.29M | Sell |
2,368
-604
| -20% | -$327K | 0.16% | 102 |
|
|
2015
Q3 | $1.38M | Buy |
2,972
+121
| +4% | +$65K | 0.15% | 116 |
|
|
2015
Q2 | $1.45M | Buy |
2,851
+127
| +5% | +$62K | 0.14% | 115 |
|
|
2015
Q1 | $1.23M | Buy |
2,724
+616
| +29% | +$261K | 0.15% | 136 |
|
|
2014
Q4 | $865K | Sell |
2,108
-284
| -12% | -$112K | 0.14% | 159 |
|
|
2014
Q3 | $862K | Buy |
2,392
+110
| +5% | +$36.9K | 0.13% | 162 |
|
|
2014
Q2 | $645K | Buy |
2,282
+242
| +12% | +$71.7K | 0.1% | 240 |
|
|
2014
Q1 | $613K | Sell |
2,040
-42
| -2% | -$12.9K | 0.11% | 237 |
|
|
2013
Q4 | $573K | Buy |
+2,082
| New | +$599K | 0.1% | 261 |
|
Other funds holding REGN
Amalgamated Bank's REGN Position: Q2 2026 in Review
Amalgamated Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 0.29% in Q2 2026, selling an estimated $37.4K and leaving 18,682 shares worth $11.6M. The position accounts for 0.08% of the portfolio, ranked #200.
Amalgamated Bank first reported a position in REGN in Q4 2013 and has held it in 51 quarters since. The position peaked at $25.2M in Q1 2023. 729 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Amalgamated Bank held 18,682 shares of Regeneron Pharmaceuticals worth $11.6M as of Q2 2026.
- Amalgamated Bank sold 55 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $37.4K.
- Regeneron Pharmaceuticals made up 0.08% of Amalgamated Bank's portfolio in Q2 2026, its #200 holding.
- Amalgamated Bank first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
- Amalgamated Bank's Regeneron Pharmaceuticals position peaked at $25.2M in Q1 2023.
- 729 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.